Added to YB: 2024-11-27
Pitch date: 2024-11-25
COV.V [bullish]
Covalon Technologies Ltd.
-45.67%
current return
Author Info
Neglected Value Chronicles focuses on small / microcaps in unloved markets. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
Market Cap
CAD 65.8M
Pitch Price
CAD 3.31
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.34
P/E
27.87
EV/Sales
1.48
Sector
Biotechnology
Category
turnaround
Covalon Technologies Ltd.: A stock returning +290% YTD - poised to perform strongly in the future?
COV.V: Collagen & vascular access products. New CEO drove turnaround: GM 52% to 63%, EBIT -31% to 21%. Collagen 70% rev, 15% mkt share. Vascular 30% rev, <1% share, high growth. YTD growth: vascular 59%, collagen 62%. Run-rate EV/E 14x, FY26E 10x. Risks: Solventum recovery, distributor dependency, pricing pressure, Chinese competition, cyclical studies, OPEX scaling.
Read full article (5 min)